About the Authors

Gavin J. Wright

gw2@sanger.ac.uk (GJW); julian.rayner@sanger.ac.uk (JCR)

Affiliations Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Malaria Programme, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Julian C. Rayner

gw2@sanger.ac.uk (GJW); julian.rayner@sanger.ac.uk (JCR)

Affiliation Malaria Programme, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

Competing Interests

The authors have a patent application related to the utility of Plasmodium falciparum merozoite antigens as vaccine candidates. This does not alter our adherence to all PLOS policies on sharing data and materials.